Internet Archive Scholar

Optimum Bioconjugated TNF-α Selectively Enhances Antitumor Potency and Reduces Side Effects
TNF-αの多様なin vivo生理作用の中から,目的とする抗腫瘍作用と副作用を分離し得るBioconjugation設計の確立

Yoko Yamamoto, Yoshihisa Kaneda, Shin-ichi Tsunoda, Haruhiko Kamada, Hiroshi Kodaira, Yasuo Tsutsumi, Yuko Ito, Takashi Hirano, Tadanori Mayumi
1998 Journal of Pharmaceutical Science and Technology, Japan  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (853.2 kB)
https://web.archive.org/web/20220817055649/https://www.jstage.jst.go.jp/article/jpstj/58/1/58_37/_pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

doi:10.14843/jpstj.58.37 fatcat:w77ginprtva75oaqivlp4xaazm
lang:ja
Citation

Yoko Yamamoto, Yoshihisa Kaneda, Shin-ichi Tsunoda, Haruhiko Kamada, Hiroshi Kodaira, Yasuo Tsutsumi, Yuko Ito, Takashi Hirano, Tadanori Mayumi. "Optimum Bioconjugated TNF-α Selectively Enhances Antitumor Potency and Reduces Side Effects." Journal of Pharmaceutical Science and Technology, Japan 58.1 (1998) 37-45